Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tripterygium wilfordii ethyl acetate extract is a pharmaceutical-grade herbal extract derived from the roots of the Chinese medicinal plant *Tripterygium wilfordii* Hook F, commonly known as Thunder God Vine. The extract is produced through a standardized sequential extraction process using ethanol followed by ethyl acetate. Its therapeutic activity is primarily attributed to diterpenoid epoxides, most notably triptolide and tripdiolide, which possess potent anti-inflammatory and immunosuppressive properties. The extract has been clinically evaluated in the United States for the treatment of autoimmune and inflammatory diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. Its biological mechanism involves the inhibition of pro-inflammatory cytokine production and the modulation of T-cell and B-cell responses, partly through the inhibition of the transcription factor NF-kappaB and the targeting of the XPB subunit of the TFIIH complex, which interferes with RNA polymerase II-mediated transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tripterygium wilfordii ethyl acetate extract.